What happens when you take DEHP’s molecular structure, saturate the aromatic ring, and keep everything else identical? You get DEHCH — the closest non-phthalate structural analog to DEHP on the market. For formulators evaluating DEHP replacements, DEHCH offers a processing transition that no other alternative can match. But that structural closeness only matters if your target application has the regulatory coverage to support it.
The regulatory landscape is shifting toward non-phthalate plasticizers faster than most procurement teams anticipated. DEHCH sits in a unique position within this shift: structurally derived from DEHP, regulatory-approved for food contact, yet still narrower in market penetration than DOTP or DINCH. Choosing between DEHCH and DEHP — or more accurately, choosing DEHCH over other DEHP alternatives — requires understanding where that structural similarity pays off and where it does not.
How DEHCH Relates to DEHP Chemically
DEHCH (bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate, CAS 84731-70-4) is produced by hydrogenating DEHP’s aromatic ring. The process adds six hydrogen atoms to convert the flat benzene ring into a three-dimensional cyclohexane ring, while preserving the same 2-ethylhexyl alcohol side chains. The molecular formula changes from C24H38O4 to C24H44O4.
This is not a minor structural tweak. That aromatic ring is precisely what drives DEHP’s classification as a reproductive toxicant — the flat, electron-rich benzene structure interacts with hormone receptors. Saturating it eliminates the endocrine disruption mechanism while keeping the molecular architecture that determines processing behavior.
The numbers confirm the closeness. DEHCH’s molecular weight is 396.6 g/mol versus DEHP’s 390.56 — a difference of just 6 g/mol representing those six added hydrogen atoms. Density runs 0.959 g/cm3 for DEHCH against 0.985 for DEHP. Water solubility drops from 285 ug/L (DEHP) to 47 ug/L (DEHCH), which means lower migration potential in aqueous applications.
Compared to traditional phthalates, no other non-phthalate alternative preserves this degree of molecular similarity. DOTP uses terephthalic acid (a para-isomer) with a completely different ring structure. DINCH uses isononyl alcohol chains instead of 2-ethylhexyl — a different compound entirely despite the similar cyclohexanoate backbone.
Performance and Processing Comparison
DEHCH’s structural similarity translates directly into processing familiarity. Formulators switching from DEHP to DEHCH face the smallest adjustment window of any non-phthalate transition.
| Property | DEHCH | DEHP |
|---|---|---|
| Molecular weight (g/mol) | 396.6 | 390.56 |
| Boiling point (C) | 406.4 | 386 |
| Viscosity | 30-50 mPa.s at 25 C | 78.17 mm2/s |
| Flash point (C) | >= 190 | 207 |
| Ester content (%) | >= 99.5 | >= 99.5 |
| Water solubility (ug/L) | 47 at 20 C | 285 at 24 C |
The higher boiling point (406 C vs 386 C) means lower volatility during processing — less plasticizer loss at elevated temperatures. DEHCH’s lower viscosity (30-50 mPa.s versus DEHP’s 78 mm2/s) actually makes it easier to handle during compounding, with faster absorption into the PVC matrix.
Processing behavior matches DEHP closely, with gelation speed faster than both DOTP and DINCH. For PVC compounders running established DEHP formulations, this means shorter qualification cycles than switching to terephthalate or citrate-based alternatives. Weather resistance exceeds DEHP, an advantage for outdoor applications like wire and cable jacketing.
I recommend DEHCH specifically for formulators who have validated DEHP processes and want to minimize reformulation effort. The processing similarity is not marketing language — it reflects genuine molecular-level compatibility with existing equipment settings and temperature profiles.
Safety and Regulatory Status
DEHP carries an EU classification as a reproductive toxicant (category 1B under Regulation 143/2011), making it subject to REACH authorization and restricted in toys, childcare articles, and food-contact materials across most jurisdictions. DEHP’s health risks are well-documented and drive the global phase-out.
DEHCH’s safety profile is fundamentally different. The EFSA CEP Panel found no genotoxicity concerns and no adverse effects at the highest tested dose of 1,000 mg/kg body weight per day in repeated-dose toxicity studies. Migration from PVC manufactured with 25% DEHCH measured just 0.034 mg/kg food — well below the established specific migration limit (SML) of 0.05 mg/kg. The derived oral reference dose stands at 0.3 mg/kg-day.
The regulatory timeline tells the market adoption story. FDA granted food-contact clearance in 2017. EFSA published a favorable safety opinion in 2019. EU Directive 2023/1627 formally authorized DEHCH for food-contact use effective August 31, 2023. For food packaging and children’s products, the regulatory path is now clear.
One critical caveat: EFSA noted uncertainty regarding potential accumulation in humans based on toxicokinetic data. The safety case is strong but not yet as deeply studied as DOTP’s multi-decade track record. I treat this as a realistic assessment, not a red flag — the available data is favorable, and regulatory bodies have acted on it.
DEHCH exists as two positional isomers, and this distinction carries regulatory weight. The 1,4-isomer (CAS 84731-70-4) carries the FDA and EU food-contact approvals. The 1,2-isomer (CAS 84-71-9) is marketed under the same DEHCH name by some suppliers but may not carry the same regulatory clearances. Compliance requirements now include verifying the specific CAS number on certificates of analysis, not just the product name.
When DEHCH Is the Right Choice
The market trend across applications is that no single DEHP replacement works everywhere. The medical device industry spent over 30 years learning this lesson: TOTM became the standard for chemotherapy tubing, DINCH for blood storage devices, and DOTP for general medical tubing — each chosen for application-specific performance requirements. DEHCH is notably absent from the medical consensus, which reveals its current limitation.
For food-contact packaging and children’s products, DEHCH is the strongest candidate when processing compatibility with legacy DEHP formulations is a priority. The regulatory approvals are in place, the migration data supports it, and the reformulation burden is minimal.
For general-purpose PVC where phthalate-free status is required but food-contact certification is not, DOTP typically wins on cost and supply chain availability. Grupa Azoty alone operates 82 ktpa of DOTP capacity in Europe; Hanwha’s DEHCH capacity is 65,000 metric tons globally.
For medical devices, neither DEHCH nor DOTP is universally suitable — application-specific testing and regulatory pathways determine the choice, and DINCH or TOTM may be required depending on the device classification and patient contact duration.
Making the Transition
DEHCH earns its position as the most structurally direct pathway from DEHP to a non-phthalate alternative. Six hydrogen atoms and 6 g/mol separate the two molecules, and that minimal structural gap translates into the most familiar processing transition available.
But structural closeness is not a universal answer. Evaluate your specific application: if you need food-contact compliance with minimal reformulation, DEHCH is likely your best option. If you need the lowest cost per pound with the widest supply base, DOTP remains more practical. If you need medical-grade blood compatibility, look at DINCH.
Whichever direction you choose, verify the CAS number on every shipment. In a market where two different DEHCH isomers carry the same product name but different regulatory statuses, that certificate of analysis is your compliance insurance.